非限制性青光眼装置植入新技术的结果

Results of a New Technique for Implantation of Nonrestrictive Glaucoma Devices.

作者信息

Ortiz Arismendi Gabriel Enrique, Peña Valderrama Cristina Del Pilar, Albis-Donado Oscar

机构信息

Associate Professor and Chief of Glaucoma Section, Ophthalmology Unit Faculty of Medicine, Universidad Nacional de Colombia, Clinica de Ojas Bogota, DC.

Assistant Professor, Ophthalmology Unit, Faculty of Medicine Universidad Nacional de Colombia, Bogotá, DC, Colombia.

出版信息

J Curr Glaucoma Pract. 2013 Sep-Dec;7(3):130-5. doi: 10.5005/jp-journals-10008-1151. Epub 2013 Sep 6.

DOI:10.5005/jp-journals-10008-1151

PMID:26997797

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4741150/

Abstract

OBJECTIVE

To describe and present results of an original technique for nonvalved glaucoma implants.

PATIENTS AND METHODS

Thirty-five eyes of 34 patients with aggressive and/or advanced glaucomas of different causes were included. A Baerveldt implant was used in all cases, using an absorbable ligature that had been titrated to allow fow from day 1, but avoiding hypotony. Intraocular pressure (IOP) during the first 8 weeks, final IOP, visual acuity and complications were analyzed.

RESULTS

Mean preoperative IOP was 42.8 mm Hg (range: 24-64 mm Hg). IOP was 14.4, 17.2, 18.6, 19 and 16.4 mm Hg during the 1, 2, 4, 6 and 8 postoperative weeks. Mean final IOP was 13.8 ± 4.25 mm Hg, a 67.8% reduction, after a mean follow-up time of 13 months (range: 8-29 months). Twenty-nine eyes (82.9%) had complete success, two had qualifed success (5.7%) and four were failures (11.4%). Choroidal detachments and transient tube obstructions were the most frequent complications.

CONCLUSION

Titrated ligature of Baerveldt tubes was effective for controlling IOP during both the early and late postoperative phases in eyes with severe glaucomas. How to cite this article: Arismendi GEO, del Pilar Peña Valderrama C, Albis-Donado O. RESULTS of a New Technique for Implantation of Nonrestrictive Glaucoma Devices. J Current Glau Prac 2013;7(3):130-135.

摘要

目的

描述并展示一种用于非瓣膜性青光眼植入物的原创技术的结果。

患者与方法

纳入34例不同病因的侵袭性和/或晚期青光眼患者的35只眼。所有病例均使用Baerveldt植入物，采用可吸收结扎线，该结扎线经过滴定，从第1天起允许房水流动，但避免低眼压。分析术后前8周的眼压（IOP）、最终眼压、视力及并发症。

结果

术前平均眼压为42.8 mmHg（范围：24 - 64 mmHg）。术后第1、2、4、6和8周时眼压分别为14.4、17.2、18.6、19和16.4 mmHg。平均随访时间为13个月（范围：8 - 29个月）后，最终平均眼压为13.8 ± 4.25 mmHg，降低了67.8%。29只眼（82.9%）完全成功，2只眼（5.7%）取得合格成功，4只眼（11.4%）失败。脉络膜脱离和短暂的引流管阻塞是最常见的并发症。